Vera Therapeutics, Inc. (NASDAQ: VERA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT VERA THERAPEUTICS, INC.

Vera Therapeutics, Inc. (NASDAQ: VERA)
Listen to this Section


$32.28
-0.0100 ( -0.03% ) 0.0K

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Market Data


Open $32.28
Previous Close $32.29
Volume 0.0K
Market Cap $2.32B
Day Range $32.56 - $32.63
52 Week Range $19.07 - $56.05
Shares Outstanding 71.78M
Change % -0.03%
Net Change ▼ -0.0100
Insider Ownership -0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,631,298.00

Date Type Amount Purchased Purchaser
2025-06-25 Buy 69798.00 ENRIGHT PATRICK G
2024-07-03 Sale -160000.00 JOHNSON DAVID LEE
2024-06-11 Sale -25000.00 Oliger Christy J.
2024-05-17 Sale -14000.00 Katabi Maha
2024-05-17 Sale -14000.00 Morrison Scott W
2024-05-17 Sale -14000.00 SEIDENBERG BETH C
2024-05-17 Sale -8221.00 Young Joseph R
2024-05-17 Sale -14000.00 MORRISSEY MICHAEL
2024-01-18 Sale -21875.00 Young Joseph R
2024-01-18 Sale -78750.00 Fordyce Marshall

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 13, 2025
8-k 8K-related 19 Nov 06, 2025
10-q Quarterly Reports 66 Nov 05, 2025
8-k 8K-related 12 Nov 05, 2025
8-k 8K-related 15 Aug 05, 2025
10-q Quarterly Reports 66 Aug 05, 2025
8-k 8K-related 12 Aug 05, 2025
4 Insider transactions 1 Jun 25, 2025
8-k 8K-related 13 Jun 03, 2025
8-k 8K-related 47 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy